Review Opinion of the Compensation and Assessment Committee
The Compensation and Assessment Committee of Jilin Province Xidian Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as "the Company") has conducted a review of the "2026 Restricted Stock Incentive Plan (Draft)" (hereinafter referred to as "the Incentive Plan (Draft)") in accordance with the provisions of the Company Law of the People's Republic of China (hereinafter referred to as "the Company Law"), the Securities Law of the People's Republic of China (hereinafter referred to as "the Securities Law"), the Administrative Measures for Equity Incentives of Listed Companies (hereinafter referred to as "the Management Measures"), and the Articles of Association of Jilin Province Xidian Pharmaceutical Technology Development Co., Ltd. (hereinafter referred to as "the Articles of Association"). The relevant circumstances and review opinions are as follows: